tert-butyl (S)-4-(6-((5-bromo-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)pyridin-3-yl)-3-methylpiperazine-1-carboxylate

Catalog No. :
ACIMQR942
CAS No. :
1433849-64-9
Molecular Formula :
C21H28BrN5O3
Molecular Weight :
478.39

IUPAC Name:tert-butyl (S)-4-(6-((5-bromo-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)pyridin-3-yl)-3-methylpiperazine-1-carboxylate

tert-butyl (S)-4-(6-((5-bromo-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)pyridin-3-yl)-3-methylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (S)-4-(6-((5-bromo-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)pyridin-3-yl)-3-methylpiperazine-1-carboxylate
IUPAC Nametert-butyl (S)-4-(6-((5-bromo-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)pyridin-3-yl)-3-methylpiperazine-1-carboxylate
MDL No.MFCD32642023
Molecular FormulaC21H28BrN5O3
Molecular Weight478.39
SMILESC[C@H]1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(NC2=CC(Br)=CN(C)C2=O)N=C1
InChI KeySYJGZZZSDMNUIV-AWEZNQCLSA-N
CAS No.1433849-64-9

Synthetic Route by SureRoute

1. ACIMQR942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNPTK731 route compound structure diagram
    ACNPTK7311433849-58-1 In Stock
  2. Plus
  3. ACMJOF692 route compound structure diagram
    ACMJOF69214529-54-5 In Stock
  4. Then
  5. ACIMQR942 route product structure diagram
    ACIMQR9421433849-64-9
Inquiry

2. ACIMQR942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNPTK731 route compound structure diagram
    ACNPTK7311433849-58-1 In Stock
  2. Plus
  3. ACMJOF692 route compound structure diagram
    ACMJOF69214529-54-5 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACIMQR942 route product structure diagram
    ACIMQR9421433849-64-9
Inquiry

Comments (0)